Testing an oral cholera vaccine in healthy adults
Part of Infections clinical trials.
This study tests an oral cholera vaccine called PanChol in healthy adults. The goal is to see if it's safe and how the body responds. It may help protect against cholera, a serious diarrheal illness.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 to 55 years old and in good health.
- You cannot have received a cholera vaccine or had cholera before.
- You must not be pregnant, breastfeeding, or planning to become pregnant for 3 months after vaccination.
- You cannot have any stomach or immune system problems.
- You must not work with young children, food, or immunocompromised patients.
- You cannot have taken antibiotics or certain vaccines recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new oral cholera vaccine called DuoChol to see if it is safe and helps your body build protection. It might be an option for healthy adults who want to help develop a better vaccine against cholera.
This trial tests a new cholera vaccine (Biovac OCV-S) to see if it works as well as the current vaccine (Euvichol-Plus). It is for healthy people aged 1 to 45, and also for adults with HIV who are on treatment.
This trial is for children aged 2 to 14 who have not had a cholera vaccine before. It tests a safe, oral vaccine to prevent cholera, a serious diarrheal disease.
This trial tests a new cholera vaccine in healthy people ages 1 to 45. It aims to see if the vaccine is safe and creates a good immune response.
This study looks at how well the cholera vaccine and past infections protect people from getting cholera. It may help researchers understand who stays protected and for how long.
This trial tests giving the oral cholera vaccine on a longer dosing schedule than usual. It aims to see if a longer gap between doses still works well to protect people from cholera, especially helpful in places where returning for a second dose is hard.
Hear when a new Cholera Vaccination Reaction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.